Annual Review Course Bundle (2017)
In preparation for the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course is also of interest to practicing urologist preparing for the Recertification Examination as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.
Target Audience
- APN/PA
- Resident
- Urologist
Learning Objectives
At the conclusion of this course, participants will be able to:
- Apply basic, generally-accepted urological practices for superior patient care.
- Demonstrate core knowledge of urology necessary for Part I of the American Board of Urology (ABU) qualifying examination and for the recertification examination.
- Utilize AUA Guidelines for appropriate patient evaluation and management.
Friday, June 9, 2017
6:30 a.m. Registration/Breakfast
7:30 a.m. Introduction
Howard B. Goldman, MD, and Wade J. Sexton, MD
7:45 a.m. Exam Overview, Test Taking Logistics, and ABU Process
Gary E. Lemack, MD
PEDIATRIC UROLOGY
8:15 a.m. Andrew J. Kirsch, MD
Congenital Urinary Tract Abnormalities
· UPJ Obstruction, UVI Obstruction (megaureter)
· Ureteroceles
· Cystic Disease
· Posterior Urethral Valves
· Prune Belly Syndrome
· Vesicoureteral Reflux
9:15 a.m. Armando J. Lorenzo, MD
Pediatric Urinary Incontinence and Bladder Disorders
· Voiding Dysfunction and Neurogenic Bladder
· Developmental Anomalies of the Bladder
· Urinary Tract Infection and Reflux
· Management of Neurogenic and Non-Neurogenic Bladder
9:45 a.m. Break
10:00 a.m. Andrew J. Kirsch, MD
Disorders of the Genitalia/Scrotum
· Intersex
· Hypospadias
· Epispadias-Exstrophy
· Undescended Testicle, Hydroceles, Hernias
10:45 a.m. Armando J. Lorenzo, MD
Pediatric Urological Oncology
· Wilm’s Tumor and Other Renal Tumors
· Rhabdomyosarcoma
· Neuroblastoma
· Testis Tumors
11:15 a.m. Pediatric Case Studies
Andrew J. Kirsch, MD and Armando J. Lorenzo, MD
11:45 p.m. Lunch
ANATOMY AND EMBRYOLOGY
12:45 p.m. Howard B. Goldman, MD
· Applied Anatomy
· Embryology
UROLITHIASIS
2:30 p.m. Glenn M. Preminger, MD
· Epidemiology, Pathophysiology
- Evaluation and Medical Management
3:15 p.m. Break
UROLITHIASIS (cont.)
3:30 p.m. Peter G. Schulam, MD, PhD
· Surgical Management of Stone Disease
LAPAROSCOPY
4:15 p.m. Peter G. Schulam, MD, PhD
· Physiology and Complications
INFERTILITY
5:00 p.m. Paul J. Turek, MD
· Physiology and Pathophysiology of Male Reproduction
· Evaluation of the Infertile Male
· Treatment of the Infertile Male (Surgical and Non-surgical)
· Hypogonadism
· Testosterone Replacement
6:30 p.m. Meeting Adjourns for the Day
Saturday, June 10, 2017
6:30 a.m. Breakfast
PENILE AND URETHRAL CANCER
7:00 a.m. Robert G. Uzzo, MD
· Epidemiology
· Diagnosis and Staging
· Imaging and Treatment
BLADDER CANCER
7:45 a.m. Michael A. O’Donnell, MD
· Epidemiology, Anatomy, Diagnosis and Imaging
o Treatment of NMIBC/ Superficial Disease Managment
o Bladder Cancer Test Questions
8:45 a.m. Seth P. Lerner, MD, FACS
· Staging and Risk Stratification of Muscle Invasive Bladder Cancer
· Multidisciplinary Treatment including Radical Cystectomy, Lymphadenectomy, Peri-Operative Chemotherapy and Chemoradiation Therapy
· Metabolic Derangements that Occur with Diversions
· Other Bladder Sparing Treatments
· Treatment of Metastatic Disease
9:55 a.m. Bladder Cancer Questions
Seth P. Lerner, MD, FACS and Michael A. O’Donnell, MD
10:15 a.m. Break
RENAL AND URETERAL TUMORS
10:30 a.m. Robert G. Uzzo, MD
· Epidemiology, Anatomy, Diagnosis and Imaging
(Including Evaluation of Renal Masses)
o Treatment of Localized Disease (including Role of Partial Nephrectomy)
o Treatment of Metastatic Disease
o Transitional Cell Carcinoma
11:45 a.m. AUA Update
Victor W. Nitti, MD – Chair, AUA Office of Education
12:00 p.m. Lunch
RENAL MEDICINE
1:00 p.m. Daniel A. Shoskes, MD
· Renal Transplantation
· Renal Vascular Disease
· Renal Physiology (including Fluid and Electrolytes)
URINARY TRACT INFECTION
2:30 p.m. Duane R. Hickling, MD
3:30 p.m. Break
INFECTION AND INFLAMMATION
3:45 p.m. Daniel A. Shoskes, MD
· Interstitial Cystitis
· Sexually Transmitted Diseases (Gonorrhea, Chlamydia, AIDS and others)
ADRENAL
4:30 p.m. Jay T. Bishoff, MD
· Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)
· Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma and Metastatic Disease)
5:15 p.m. Meeting Adjourns for the Day
Sunday, June 11, 2017
6:30 AM Breakfast
FEMALE UROLOGY, URODYNAMICS AND NEUROUROLOGY
7:00 a.m. Stephen R. Kraus, MD
· Urodynamics Review
· Neurourology
8:00 a.m. Urodynamics Tracing Review
Stephen R. Kraus, MD and Howard B. Goldman, MD
8:15 a.m. Howard B. Goldman, MD
· Overactive Bladder/Urgency Incontinence
· Stress Urinary Incontinence
· Pelvic Organ Prolapse
· Vaginal Masses/Urethral Diverticulum
· Urinary Fistula
9:30 a.m. Break
GU RADIOLOGY
9:45 AM Brian R. Herts, MD
· Basics of MR, CT, US, VCUG
· Solid and Cystic Renal Masses (CT and MR)
· Transitional Cell Carcinoma
· Prostate MR
· Adrenal Imaging
· Scrotal Imaging
Retroperitoneal Tumors
Radiation Basic Principles
PROSTATE CANCER AND BPH
11:00 a.m. Adam S. Kibel, MD
· Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)
· Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy)
· Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure
· DVT Prophylaxis
12:30 p.m. Lunch
ERECTILE DYSFUNCTION
1:30 p.m. John P. Mulhall, MD
· Physiology of Erection, Pathophysiology of Erectile Dysfunction
· Evaluation and Management of Erectile Dysfunction
· Pathophysiology, Evaluation and Management of Priapism Pathophysiology, Evaluation and Management of Peyronie’s Disease
TESTICULAR TUMORS
2:30 p.m. Wade J. Sexton, MD
· Epidemiology, Diagnosis, Staging and Imaging (including the Role of Markers and CIS)
· Treatment of Seminoma
· Treatment of Non-Seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A,B, and C)
UROLOGIC TRAUMA
3:45 p.m. Jay Simhan, MD
- Renal and Ureteral Trauma: Evaluation and Management
- Bladder and Urethral Trauma: Evaluation and Management
- Genital Trauma: Evaluation and Management
4:45 p.m. Meeting Adjourns for the Day
Glenn M. Preminger, MD | Speaker | Nothing to Disclose | |||
Gary E. Lemack, MD | Speaker | Roivant | Consultant or Advisor | Yes | 11/17/2017 |
Armando J. Lorenzo, MD | Speaker | Nothing to Disclose | |||
Howard B. Goldman, MD | Speaker | Axonics NewUro Galvani bioness | Consultant or Advisor Consultant or Advisor Consultant or Advisor Scientific Study or Trial | Yes Yes Yes No | 04/04/2017 10/31/2017 01/15/2018 04/02/2018 |
Peter G. Schulam, MD | Speaker | Nothing to Disclose | |||
Paul J. Turek, MD | Speaker | Contraline, Inc FutureFamily, Inc | Consultant or Advisor Consultant or Advisor | Yes Yes | 10/18/2017 10/18/2017 |
Andrew Jared Kirsch,M.D. | Speaker | Nothing to Disclose |
Victor W. Nitti, MD | Speaker | Medtronic | Scientific Study or Trial | No | 04/03/2017 |
Daniel A. Shoskes, MD | Speaker | Aquinox | Consultant or Advisor | Yes | 04/03/2017 |
Jay T. Bishoff, MD | Speaker | Nothing to Disclose | |||
Robert G. Uzzo, MD | Speaker | Nothing to Disclose | |||
Michael A. O'Donnell, MD | Speaker | Nothing to Disclose | |||
Seth P. Lerner, MD, FACS | Speaker | Nothing to Disclose | |||
Duane R. Hickling, M.D. | Speaker | Pfizer | Consultant or Advisor,Meeting Participant or Lecturer | Yes | 07/20/2017 |
John P. Mulhall, MD | Speaker | Nothing to Disclose | |||
Stephen R. Kraus, MD | Speaker | Nothing to Disclose | |||
Howard B. Goldman, MD | Speaker | Axonics NewUro Galvani bioness | Consultant or Advisor Consultant or Advisor Consultant or Advisor Scientific Study or Trial | Yes Yes Yes No | 04/04/2017 10/31/2017 01/15/2018 04/02/2018 |
Adam S. Kibel, MD | Speaker | Janssen ConfirmMDx Pfizer | Consultant or Advisor Consultant or Advisor Consultant or Advisor | Yes Yes Yes | 11/12/2017 11/12/2017 03/16/2018 |
Wade Jeffers Sexton , M.D. | Speaker | Nothing to Disclose | |||
Jay Simhan, MD | Speaker | Nothing to Disclose | |||
Brian Herts ,M.D. | Speaker | Siemens Healthineers | Scientific Study or Trial | No | 10/23/2017 |